BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29048640)

  • 1. DAL-1 attenuates epithelial to mesenchymal transition and metastasis by suppressing HSPA5 expression in non-small cell lung cancer.
    Qiu X; Guan X; Liu W; Zhang Y
    Oncol Rep; 2017 Nov; 38(5):3103-3113. PubMed ID: 29048640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
    Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
    J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer.
    Chen X; Guan X; Zhang H; Xie X; Wang H; Long J; Cai T; Li S; Liu Z; Zhang Y
    J Exp Clin Cancer Res; 2015 Jan; 34(1):3. PubMed ID: 25609022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
    Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
    Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.
    Ye Z; Fang B; Pan J; Zhang N; Huang J; Xie C; Lou T; Cao Z
    Oncol Rep; 2017 Jun; 37(6):3244-3252. PubMed ID: 28498463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foxp3 downregulation in NSCLC mediates epithelial-mesenchymal transition via NF-κB signaling.
    Wang X; Liu Y; Dai L; Liu Q; Jia L; Wang H; An L; Jing X; Liu M; Li P; Cheng Z
    Oncol Rep; 2016 Oct; 36(4):2282-8. PubMed ID: 27574108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of RNF187 induces cell EMT and apoptosis resistance in NSCLC.
    Fu Z; Yu W; Wang H; Chen X
    J Cell Physiol; 2019 Aug; 234(8):14161-14169. PubMed ID: 30624778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses.
    Chang JH; Cheng CW; Yang YC; Chen WS; Hung WY; Chow JM; Chen PS; Hsiao M; Lee WJ; Chien MH
    J Exp Clin Cancer Res; 2018 Aug; 37(1):199. PubMed ID: 30134935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
    Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
    Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of 14-3-3γ Suppresses Epithelial-Mesenchymal Transition and Reduces Metastatic Potential of Human Non-small Cell Lung Cancer Cells.
    Raungrut P; Wongkotsila A; Champoochana N; Lirdprapamongkol K; Svasti J; Thongsuksai P
    Anticancer Res; 2018 Jun; 38(6):3507-3514. PubMed ID: 29848704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.
    Jiang S; Liu X; Li D; Yan M; Ju C; Sun J; Jiang F
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818797587. PubMed ID: 30198403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of expression of the differentially expressed in adenocarcinoma of the lung (DAL-1) protein is associated with metastasis of non-small cell lung carcinoma cells.
    Zhang Y; Xu R; Li G; Xie X; Long J; Wang H
    Tumour Biol; 2012 Dec; 33(6):1915-25. PubMed ID: 22782504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
    Zhu X; Guo X; Wu S; Wei L
    Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
    Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DAL-1/4.1B contributes to epithelial-mesenchymal transition via regulation of transforming growth factor-β in lung cancer cell lines.
    Yu F; Yang H; Zhang Z; Wang Z; Xiong J
    Mol Med Rep; 2015 Oct; 12(4):6072-8. PubMed ID: 26300315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.